Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
No entries.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Lipid formulation screening with vesicles
Prepare vesicles for a lipid formulation screen with a fixed fraction of bis(monoacylglycero)phosphate (BMP) and vary the surrounding phospholipids. Incubate each formulation with purified Hsp70, then add acid sphingomyelinase and vesicle-incorporated sphingomyelin. Measure ceramide formation and compare each formulation with its matched Hsp70-free control to quantify the effect of membrane composition on Hsp70-dependent activity.
Component substitution
A recombinant Hsp70 domain fragment
Replace full-length Hsp70 with its recombinant N-terminal nucleotide-binding domain. Incubate the fragment with BMP-containing vesicles and measure vesicle association by flotation before adding acid sphingomyelinase. Measure ceramide formation from vesicle-incorporated sphingomyelin and compare the fragment with full-length Hsp70 and a protein-free control.
Heat-induced Hsp70 in cultured fibroblasts
Replace direct Hsp70 addition with induction of endogenous Hsp70 in cultured mammalian fibroblasts. Expose replicate cultures to a 42 °C heat pulse for 30 minutes, allow recovery at 37 °C, and collect lysosome-enriched fractions alongside fractions from untreated cultures. Quantify Hsp70 and BMP in each fraction, measure acid sphingomyelinase activity by ceramide formation, and use a matched Hsp70 knockdown culture to distinguish Hsp70-dependent activity changes from other heat responses.
Parameter or scale variation
BMP fraction and acidity series
Prepare vesicles containing 0, 5, 10, or 20 mole percent BMP by exchanging BMP for phosphatidylcholine at fixed total lipid and sphingomyelin concentrations. Run each composition at pH 4.5, 5.0, and 5.5 with paired reactions containing either 0 or 0.5 micromolar Hsp70. After adding acid sphingomyelinase, measure ceramide at 0, 2, and 5 minutes and compare the initial rates within each composition and pH pair.
Combination with existing systems
BMP vesicles in a flow cell
Capture BMP-containing vesicles on a flow-cell sensor through a biotinylated lipid anchor. Perfuse Hsp70 over the captured vesicles, then introduce acid sphingomyelinase while recording the surface response. Quantify phosphorylcholine in timed effluent fractions by liquid chromatography coupled to mass spectrometry and compare it with a parallel channel supplied with buffer during the Hsp70 step.
Automated or data-driven variant
Automated measurement of reaction rates
Use a liquid handler to dispense BMP-containing vesicles with a fluorescent sphingomyelin analog into a microplate, then add an Hsp70 dilution series and acid sphingomyelinase. At programmed intervals, transfer aliquots to quench wells and separate the fluorescent ceramide product from the substrate by liquid chromatography. Software integrates the product peaks, fits initial rates, and subtracts the rate measured in matched wells without Hsp70.
Cite aspatent.fyi, US 2026/0355174 A1, claim 1, first published 2026-11-19T09:07:06-05:00, https://patent.fyi/US20260355174/, SHA-256 a02aad0b6f5792041e7def6215e54d09c65b9541a8071c85c91de2a5796c4597